Navigation Links
EntreMed Reports First Quarter 2013 Financial Results
Date:5/15/2013

ROCKVILLE, Md., May 15, 2013 /PRNewswire/ -- EntreMed, Inc. (NASDAQ: ENMD), a clinical-stage pharmaceutical company, today reported financial results for the three months ended March 31, 2013. 

(Logo: http://photos.prnewswire.com/prnh/20010620/ENMDLOGO )

The Company reported a net loss for the first quarter of approximately ($1.1 million), or ($0.05) per share, compared with a net loss of ($2.5 million), or ($0.23) per share, for the same period last year.  The reported net loss for the three months ended March 31, 2012 included non-cash interest charges totaling approximately $0.9 million associated with the Company's 2012 financing, recorded in accordance with US generally accepted accounting principles. For the three months ended March 31, 2012, the net loss, excluding non-cash interest expense, was ($1.6 million), or ($0.16) per share.

As of March 31, 2013, EntreMed had cash and cash equivalents of approximately $18.3 million, which includes approximately $10.3 million in net proceeds from a financing which was completed on March 14, 2013.

Sara B. Capitelli , Vice President, Finance and Principal Accounting Officer, commented, "Our financial resources were dedicated primarily to the clinical development of our lead drug candidate, ENMD-2076.  Our financial results for the first quarter are in line with our expectations. Research and development expenses for the first quarter of 2013 decreased compared to the previous year, reflecting the absence of severance related costs in the 2013 period, offset by increased costs associated with the clinical development of ENMD -2076 in the U.S. and China during 2013.  Our general and administrative expenses for the first quarter of 2013 also decreased compared to the
'/>"/>

SOURCE EntreMed, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Patent Issued In China For EntreMeds Lead Drug Candidate ENMD-2076
2. Patent Issued In U.S. For EntreMeds 2ME2 In Rheumatoid Diseases
3. EntreMed Announces Changes to Board of Directors and CEO Appointment
4. EntreMed Reports Fourth Quarter And Year-End 2012 Financial Results And Business Outlook For 2013
5. EntreMed To Raise $10.7 Million In Registered Direct Offering
6. EntreMed Announces Initiation Of Phase 2 Trial In Advanced/Metastatic Soft Tissue Sarcoma
7. PNAS Publishes Preclinical Results of EntreMeds 2ME2 for Multiple Sclerosis
8. EntreMed Announces Publication Of Preclinical Results For ENMD-2076 In Triple-negative Breast Cancer
9. Dana-Farber Cancer Institutes Ursula A. Matulonis, MD Article on EntreMeds ENMD-2076 Published in the European Journal of Cancer
10. EntreMed Reports Second Quarter 2012 Financial Results
11. EntreMed Announces Initiation Of Phase 2 Trial In Triple-negative Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... , Aug. 27, 2014 Reportlinker.com ... available in its catalogue: Global Heart ... http://www.reportlinker.com/p02316644/Global-Heart-Valve-Repair-and-Replacement-Market-2014-2018.html About Heart ... in the human heart which control the flow ... affected with heart valve diseases such as valvular ...
(Date:8/27/2014)... Aug. 27, 2014 Reportlinker.com announces that ... its catalogue: Global Animal Health Market ... About Animal Health Animal health refers to ... treat animals to enhance their quality of life, ... animal food. The Global Animal Health market covers ...
(Date:8/27/2014)... , Aug. 27, 2014 Kewaunee Scientific ... Board of Directors increased its quarterly cash dividend by ... cents per outstanding share, beginning with the dividend payable ... the close of business on September 8, 2014. ... Founded in 1906, Kewaunee Scientific Corporation is a recognized ...
Breaking Medicine Technology:Global Heart Valve Repair and Replacement Market 2014-2018 2Global Heart Valve Repair and Replacement Market 2014-2018 3Global Heart Valve Repair and Replacement Market 2014-2018 4Global Animal Health Market 2014-2018 2Global Animal Health Market 2014-2018 3Global Animal Health Market 2014-2018 4Global Animal Health Market 2014-2018 5Global Animal Health Market 2014-2018 6Global Animal Health Market 2014-2018 7
... YORK, March 7, 2012  The Alzheimer,s Drug Discovery ... (AFTD) announced today the recipients of their fifth ... Program.   The goal of the ... therapies for frontotemporal degeneration (FTD).  ...
... OAKS, Calif., March 7, 2012  Amgen Inc. ("Amgen") (NASDAQ: ... offering period of the tender offer (the "Offer") by a ... of common stock of Micromet, Inc. ("Micromet") (NASDAQ: ... offering period expired at 12:00 midnight, New York City time, ...
Cached Medicine Technology:Awards for Drug Discovery Research for Frontotemporal Degeneration Announced 2Awards for Drug Discovery Research for Frontotemporal Degeneration Announced 3Amgen Completes Tender Offer for Outstanding Shares of Micromet, Inc. 2Amgen Completes Tender Offer for Outstanding Shares of Micromet, Inc. 3Amgen Completes Tender Offer for Outstanding Shares of Micromet, Inc. 4
(Date:8/27/2014)... NJ (PRWEB) August 27, 2014 New ... finish at The Ridgewood County Club during The Barclays ... board in each of the tournament’s four rounds, stepped ... the Horizon Blue Cross Blue Shield of New Jersey ... challenged Hoffmann, a Wyckoff native playing before family and ...
(Date:8/27/2014)... topical agents and light to kill tissue) appears to ... caused by sun damage) at three months after treatment ... , Author: Gayatri Patel, M.D., M.P.H., of ... and colleagues. , Background: AKs are rough, ... with fair complexions who have had lots of sun ...
(Date:8/27/2014)... 2014 Sound Telecom, a leading telecommunications ... cloud-based business communication systems, has unveiled an article titled ... Secure Text Messaging .” The piece examines the world ... do to remain compliant with HIPAA and HITECH requirements. ... and C.O.O. at Sound Telecom, opens with evidence that ...
(Date:8/27/2014)... NY (PRWEB) August 27, 2014 ... physicians and nurses by healthcare research group Black ... hospitals are not adequately staffed, supplied or built ... , “Black Book initiated this annual survey to ... around hospital infection control, epidemiology and emergency preparedness ...
(Date:8/27/2014)... Lee Antimicrobial Solutions LLC (“LAMS”), the ... and a Leader in Environmental Disinfection Device Design, ... device developed for home use available for the ... DHP Technology, a revolutionary means to disinfect your ... bacteria, viruses, microbes and offensive odors. A technology ...
Breaking Medicine News(10 mins):Health News:Morgan Hoffmann, PGA TOUR Pro & Wyckoff Native, golfs and walks his way to top 10 finish at The Barclays while raising additional $7,500 for charity 2Health News:Photodynamic therapy vs. cryotherapy for actinic keratoses 2Health News:Sound Telecom Releases Article on Secure Messaging with Huge Implications for the Healthcare Industry 2Health News:Sound Telecom Releases Article on Secure Messaging with Huge Implications for the Healthcare Industry 3Health News:American Hospitals Are Vastly Unprepared for Ebola Patients, Reveals Black Book™ Survey of Emergency Physicians, Nurses and Infection Control Practitioners 2Health News:American Hospitals Are Vastly Unprepared for Ebola Patients, Reveals Black Book™ Survey of Emergency Physicians, Nurses and Infection Control Practitioners 3Health News:American Hospitals Are Vastly Unprepared for Ebola Patients, Reveals Black Book™ Survey of Emergency Physicians, Nurses and Infection Control Practitioners 4Health News:A New York Based Company Announces The Release Of An Advanced, Environmentally Friendly Disinfection Technology For In-Home Use 2Health News:A New York Based Company Announces The Release Of An Advanced, Environmentally Friendly Disinfection Technology For In-Home Use 3
... , , , --Monday, June 29, 2009 at Red ... years at Red Rocks -- , , DENVER, June ... a benefit concert by the Mormon Tabernacle Choir and Orchestra at Temple ... 2009. Over 23,000 athletes are served annually through the NSCD. ...
... NUVA ), a medical device company focused on ... announced today that Stephan S. Ogilvie, Senior Director of Business ... Life Sciences Conference at the New York Palace Hotel in ... 11:00 a.m. Eastern Time. , , A live ...
... Inc. (Nasdaq: TRBN ) announced today that executives ... Needham Life Sciences Conference to be held at the New ... co-founder and senior vice president of research and development, and ... scheduled to present on Wednesday, June 10 at 2:00 pm ...
... WHITE PLAINS, N.Y., June 4 Celebrity volunteers who led more than ... public to continue to help the March of Dimes raise urgently needed ... , "As a mom who had a premature child, I know ... babies and families by joining me in supporting the March of Dimes," ...
... INTEGRATED SPONSORSHIP WITH STACKER 2 - 6 HOUR POWER EXTREME ENERGY ... , NASHVILLE, Tenn., June 4 Total ... 2 - 6 Hour Power Extreme Energy Shot. The sponsorship will ... exposure, and on many other digital platforms. , ...
... , MIAMI, June 4 St. Jude Children,s Research Hospital(R) ... by honoring Tommy and Thalia Mottola on May ... Estefan , co-host of the popular Univision show El ... the 2009 Al-Rashid Hope Award for their commitment to children,s ...
Cached Medicine News:Health News:Mormon Tabernacle Choir Benefit Concert Helps Colorado Disabled Iraqi War Veteran and National Sports Center for the Disabled Athletes 2Health News:NuVasive to Present at the 8th Annual Needham Life Sciences Conference 2Health News:NuVasive to Present at the 8th Annual Needham Life Sciences Conference 3Health News:Trubion to Present at the 8th Annual Needham Life Sciences Conference 2Health News:Celebrities Lead One Million Walkers and Urge Public to Support March for Babies(R) 2Health News:Celebrities Lead One Million Walkers and Urge Public to Support March for Babies(R) 3Health News:Total Nonstop Action (TNA) Wrestling Gets Energized with the Extreme Energy Shot! 2Health News:Photos: Tommy & Thalia Mottola Honored at 7th Annual FedEx/St. Jude Angels & Stars Gala 2Health News:Photos: Tommy & Thalia Mottola Honored at 7th Annual FedEx/St. Jude Angels & Stars Gala 3
... Design for Neurosurgery. The neuroview family ... therapeutic minimally invasive procedures. Available in ... offer working channels for instrument use ... body and steerable tip, the surgeon ...
... High Performance Instrument System. It is the ... of electric power with the unparalleled high ... Anspach. The advanced design of this instrument ... integrated cooling system, advanced control circuitry, and ...
... Performance Instrument System was developed ... increased power of the Neurosurgeon ... provides 60% more torque than ... handle the most demanding craniotomies ...
Legend Gold is the most powerful of the new motors. It runs at an impressive 76,000 rpm at 120 psi/8 bar. It is also smaller than the Midas Rex Classic motor, with an enhanced ergonomic design....
Medicine Products: